Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway

Andrographolide (Andro) is a traditional anti-inflammatory drug used in the clinic that inhibits NF-κB activation. It could be an antitumor agent for the treatment of luminal-like breast cancer in the clinic. #biology #biotech #biotechnology #LifeSciences

New Research: Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway: Tumor growth and metastasis are responsible for breast cancer-related mortality.… https://t.co/oU14L